Literature DB >> 21788435

Concentrations of IGF-I and IGFBP-3 and brain tumor risk in the European Prospective Investigation into Cancer and Nutrition.

Sabine Rohrmann1, Jakob Linseisen, Susen Becker, Naomi Allen, Brigitte Schlehofer, Kim Overvad, Anja Olsen, Anne Tjønneland, Beatrice S Melin, Eiliv Lund, Paolo Vineis, Sara Grioni, Rosario Tumino, Domenico Palli, Amalia Mattiello, Catalina Bonet, Maria-Dolores Chirlaque, María-José Sánchez, Laudina Rodríguez, Miren Dorronsoro, Eva Ardanaz, Pagona Lagiou, Antonia Trichopoulou, Dimitrios Trichopoulos, Laure Dossus, Verena A Grote, Heiner Boeing, Krasimira Aleksandrova, H Bas Bueno-de-Mesquita, Fränzel J B van Duijnhoven, Petra H M Peeters, Kay-Tee Khaw, Nicholas J Wareham, Timothy J Key, Sabina Rinaldi, Isabelle Romieux, Valentina Gallo, Dominique S Michaud, Elio Riboli, Rudolf Kaaks.   

Abstract

BACKGROUND: Insulin-like growth factor-1 (IGF-I) is important in normal brain development but in the adult brain, IGF-I overexpression may be a risk factor for tumor development.
METHODS: We examined the association between circulating concentrations of IGF-I and IGFBP-3 in relation to risk of gliomas (74 low-grade, 206 high-grade gliomas), meningiomas (n = 174) and acoustic neuromas (n = 49) by using a case-control design nested in the European Prospective Investigation into Cancer and Nutrition. IGF-I and IGFBP-3 were measured by ELISAs.Conditional logistic regression was used to compute ORs and corresponding 95% CIs.
RESULTS: The risk of low-grade gliomas was elevated with increased IGF-I (OR = 3.60, 95% CI: 1.11-11.7; top vs. bottom quartile) and decreased with elevated IGFBP-3 concentrations (OR = 0.28, 95% CI: 0.09-0.84) after mutual adjustment of these two factors; these results became nonsignificant after exclusion of the first year of follow-up. No association was observed for high-grade gliomas or meningiomas. Both high IGF-I and IGFBP-3 concentrations were associated with risk of acoustic neuromas (IGF-I: OR = 6.63, 95% CI: 2.27-19.4, top vs. bottom tertile; IGFBP-3: OR = 7.07, 95% CI: 2.32-21.6), even after excluding the first year of follow-up.
CONCLUSION: High concentrations of IGF-I might be positively associated with risk of low-grade gliomas and acoustic neuromas, although we cannot exclude reverse causation, in particular for low-grade gliomas. IMPACT: Factors of the IGF axis might be involved in the etiology of some types of brain tumors. ©2011 AACR

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21788435     DOI: 10.1158/1055-9965.EPI-11-0179

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  18 in total

Review 1.  Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma.

Authors:  Angela Poff; Andrew P Koutnik; Kathleen M Egan; Solmaz Sahebjam; Dominic D'Agostino; Nagi B Kumar
Journal:  Semin Cancer Biol       Date:  2017-12-30       Impact factor: 15.707

2.  Diabetes, use of antidiabetic drugs, and the risk of glioma.

Authors:  Corinna Seliger; Cristian Ricci; Christoph R Meier; Michael Bodmer; Susan S Jick; Ulrich Bogdahn; Peter Hau; Michael F Leitzmann
Journal:  Neuro Oncol       Date:  2015-06-20       Impact factor: 12.300

3.  Inhibition of intracerebral glioblastoma growth by targeting the insulin-like growth factor 1 receptor involves different context-dependent mechanisms.

Authors:  Martin Zamykal; Tobias Martens; Jakob Matschke; Hauke S Günther; Annegret Kathagen; Alexander Schulte; Regina Peters; Manfred Westphal; Katrin Lamszus
Journal:  Neuro Oncol       Date:  2014-12-27       Impact factor: 12.300

4.  Perinatal and familial risk factors for brain tumors in childhood through young adulthood.

Authors:  Casey Crump; Jan Sundquist; Weiva Sieh; Marilyn A Winkleby; Kristina Sundquist
Journal:  Cancer Res       Date:  2014-12-15       Impact factor: 12.701

5.  Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study.

Authors:  José M Garcia; John Friend; Suzan Allen
Journal:  Support Care Cancer       Date:  2012-06-16       Impact factor: 3.603

6.  Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas.

Authors:  Pei-Fang Wu; Wen-Chang Huang; James Chih-Hsin Yang; Yen-Shen Lu; Jin-Yuan Shih; Shang-Gin Wu; Ching-Hung Lin; Ann-Lii Cheng
Journal:  J Neurooncol       Date:  2013-07-02       Impact factor: 4.130

7.  A prospective study of height and body mass index in childhood, birth weight, and risk of adult glioma over 40 years of follow-up.

Authors:  Cari M Kitahara; Michael Gamborg; Preetha Rajaraman; Thorkild I A Sørensen; Jennifer L Baker
Journal:  Am J Epidemiol       Date:  2014-09-09       Impact factor: 4.897

8.  Relationship between concentrations of IGF-1 and IGFBP-3 and preoperative depression risk, and effect of psychological intervention on outcomes of high-grade glioma patients with preoperative depression in a 2-year prospective study.

Authors:  Yan Wang; Ming Huang; Jian-tong Jiao; Yan-li Wu; Tao-hui Ouyang; Ju Huang; Sha-sha Liu; Chun-lin Li
Journal:  Med Oncol       Date:  2014-03-26       Impact factor: 3.064

9.  Biomarker patterns of inflammatory and metabolic pathways are associated with risk of colorectal cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).

Authors:  Krasimira Aleksandrova; Mazda Jenab; H Bas Bueno-de-Mesquita; Veronika Fedirko; Rudolf Kaaks; Annekatrin Lukanova; Fränzel J B van Duijnhoven; Eugene Jansen; Sabina Rinaldi; Isabelle Romieu; Pietro Ferrari; Neil Murphy; Marc J Gunter; Elio Riboli; Sabine Westhpal; Kim Overvad; Anne Tjønneland; Jytte Halkjær; Marie-Christine Boutron-Ruault; Laure Dossus; Antoine Racine; Antonia Trichopoulou; Christina Bamia; Philippos Orfanos; Claudia Agnoli; Domenico Palli; Salvatore Panico; Rosario Tumino; Paolo Vineis; Petra H Peeters; Eric J Duell; Esther Molina-Montes; J Ramón Quirós; Miren Dorronsoro; Maria-Dolores Chirlaque; Aurelio Barricarte; Ingrid Ljuslinder; Richard Palmqvist; Ruth C Travis; Kay-Tee Khaw; Nicholas Wareham; Tobias Pischon; Heiner Boeing
Journal:  Eur J Epidemiol       Date:  2014-05-04       Impact factor: 8.082

10.  Circulating Insulin-Like Growth Factor-1 and Risk of Total and 19 Site-Specific Cancers: Cohort Study Analyses from the UK Biobank.

Authors:  Frank Qian; Dezheng Huo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-08-20       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.